• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hadasit Bio Holdings Ltd

+ Add to Watchlist


16.60 ILs 0.10 0.61%

As of 05:56:40 ET on 12/22/2014.

Snapshot for Hadasit Bio Holdings Ltd (HDST)

Open: 16.50 Day's Range: 16.00 - 16.60 Volume: 110,693
Previous Close: 16.50 52wk Range: 14.40 - 28.60 1-Yr Rtn: -35.66%

Stock Chart for HDST

No chart data available.
  • HDST:IT 16.50
  • 1D
  • 1M
  • 1Y
Interactive HDST Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HDST

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -0.0742
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 23.70
Shares Outstanding (M) 142.78
30 Day Average Volume 125,019
Price/Book (mrq) 1.1933
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HDST

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for HDST

Hadasit Bio-Holdings Ltd., through subsidiaries, develops and researches diagnostic and treatment products and vaccinations. The Company researches products used to diagnose tumor malignancies, radiology-based products to diagnose, monitor and treat cancer, products to manage stroke, heart attack, and inflammatory and autoimmune diseases, and a rheumatoid arthritis vaccine.

Tami KfirChief Executive OfficerLiat HadadChief Financial Officer
More Company Profile & Key Executives for HDST

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link

Press Releases for HDST

Sponsored Links
sec ||= nil